Key result
Coronary flow stimulates glycolytic flux in isolated guinea pig hearts, a response inhibited by concanavalin A and heparinase, implicating specific endothelial glycocalyx components.
Coronary flow stimulates myocardial glycolytic flux through shearing forces acting on specific components of the endothelial glycocalyx.
No practice change from guinea pig data; hypothesis-generating for glycocalyx-mediated cardiac metabolism.
Hemodynamic forces continuously act on endothelial cell lining of blood vessels. Blood flow, perfusing pressure, and shear stress are known to induce the release of bioactive substances from the endothelium. Furthermore, coronary flow (CF) is a well-known stimulant of myocardial contraction. Our concern was whether other Ca(2+)-dependent responses like glycolytic flux (Gf) were also CF dependent. For this purpose, isolated guinea pig hearts were perfused with a medium containing 5 mM 3-[3H]glucose, and the 3H2O released during perfusion was measured as an index of Gf. Changes in CF within the 3- to 25-ml/min range resulted in linear increase of Gf. This stimulatory effect of CF was also observed in K(+)-arrested hearts. In addition, increasing shear stress on addition of dextran to the perfusing solution (5% and 10% wt/vol), while keeping CF constant, also stimulated Gf. We hypothesized that endothelial cell membrane glycocalyx may act as sensor to this stimuli. Thus one would expect that substances acting on these structures (enzymes heparinase, hyaluronidase, or chondroitinase or the lectin concanavalin A) when added to the perfusate might inhibit the CF-induced Gf. The results showed that concanavalin A and heparinase inhibited the Gf-CF-induced response, whereas chondroitinase and hyaluronidase had no effect. These findings suggest that there may be a selective effect of these agents affecting the Gf response to CF. Our data suggest that CF stimulates Gf through shearing forces acting on specific endothelial glycocalyx component(s). Therefore, deformation of these components could result in the transduction of physical signals into release of chemical messengers that act on the biochemical machinery of underlining parenchymal cells.
No takes yet. Share an insight, caveat, or question.
Suárez et al. (1991) studied this question. Coronary flow variations and glycocalyx-modifying agents was evaluated on Glycolytic flux (Gf) measured by 3H2O release. Coronary flow stimulates glycolytic flux in isolated guinea pig hearts, a response inhibited by concanavalin A and heparinase, implicating specific endothelial glycocalyx components.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: